Session 2: Drug Delivery, Pharmacokinetics/Pharmacodynamics, ADME, Permeation and Transport, Binding

Browse by

PS44-PS85

Recent Submissions

Extraction and Metabolism of NNK in the Isolated Perfused Lung System

Maertens, Laura A.; Hecht, Stephen S.; Zimmerman, Cheryl L. (2006-10-27)
Experimental pitfalls in protein binding measurements

Schmidt, Stephan; Derendorf, Hartmut; Sahre, Martina; Burkhardt, Olaf (2006-10-27)
Discovery and evaluation of novel mura inhibitors

Han, Huijong; Schönbrunn, Ernst (2006-10-27)
The study of skin permeation mechanism and terpene-skin lipid interaction via nuclear magnetic resonance

Lim, Perry Fung Chye; Liu, Xiang Yang; Huang, Meng; Ho, Paul Chi Lui; Chan, Sui Yung (2006-10-27)
Interaction of lopinavir with MDR1, MRP1 and MRP2 efflux proteins

Agarwal, Sheetal; Pal, Dhananjay; Mitra, Ashim K. (2006-10-27)
In vitro intestinal transport of a poorly aqueous soluble drug and p-glycoprotein efflux using biorelevant medium simulating the intestinal fluids

Lind, Marriane L.; Jacobsen, Jette; Holm, René; Müllertz, Annette (2006-10-27)
Influence of lipid content of a liposome formulation used for solubilization of a poorly water-soluble drug on absorption through Caco-2 monolayers

Schneider, M.; Imanidis, G. (2006-10-27)
Automated permeability assessment of drugs formulated as solid dosage forms by means of sequential injection technique (SIA)

Motz, Stephan A.; Klimundová, Jana; Schaefer, Ulrich F.; Balbach, Stefan; Eichinger, Thomas; Solich, Petr; Lehr, Claus-Michael (2006-10-27)
Lymphatic absorption of subcutaneously administered proteins in sheep: Influence of different injection sites

Kota, J.; Porter, C. J. H.; Edwards, G. A.; McLennan, D. N.; Machavaram, K.; Charman, S. A. (2006-10-27)
Physicochemical investigations of a drug delivery oscillator

Bhalla, A. S.; Siegel, R. A. (2006-10-27)
Delivery of neuroactive peptide drugs to the brain via intranasal delivery

Cros, Cecile D.; Toth, Istvan; Blanchfield, Joanne T. (2006-10-27)
Biochemical characterization of derivatives of MA-T12D11, a TAFI neutralizing antibody

Develter, J.; Declerck, P. J.; Gils, A. (2006-10-27)
Targeting carrier-mediated transport to improve the blood-brain barrier permeation of paclitaxel

Desino, Kelly Elizabeth; Audus, Kenneth L.; Ge, Haibo; Georg, Gunda I.; Oyetunji, Jariat; Spletstoser, Jared T.; Turunen, Brandon J. (2006-10-27)

Contact KU ScholarWorks
Lawrence, KS | Maps

The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

Contact KU
Lawrence, KS | Maps